Delivery Order SPE2DB22D2206-SPE2DB24FJA00
Award Date
7/1/24
Potential Completion Date
7/2/24
Potential Value
$40K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $8,001.99. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a...
This contract award is for the delivery of Dupixent 300 mg/2 ml syringes, worth $9,781.95, to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp. The contract is a Firm Fixed Price Delivery Order with a completion date of July 2, 2024. Amerisourcebergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,488.44 and an ultimate completion date of November 14, 2024. It is a Firm Fixed Price delivery order contract awarded under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of Dupixent 200 mg/1.14 ml syringes to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 30, 2024, with a ceiling value of $3,304.72 and a completion date of January 31, 2024. The contract is a delivery order under a firm fixed-price contract type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $14,191.54 and is a firm fixed price delivery order with a completion date of June 4, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA). The contract, valued at $5,988.39, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order and has a firm fixed price pricing type. It does not have a set-aside designation, indicating open competition. The award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of Dupixent 200 mg/1.14 ml syringes to the Defense Logistics Agency (DLA). The contract, valued at $5,241.37, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a wide range of medical...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to support the Defense Logistics Agency's (DLA) medical supply needs. The $9,803.90 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 4, 2024, with an ultimate completion date of November 5, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that is a subsidiary of the parent company Cencora, Inc. The contract, a Delivery Order valued at $13,233.34, has a completion date of March 7, 2024 and uses a Firm Fixed Price pricing type. There is no set-aside designation for this award. Amerisourcebergen holds a significant...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA). The contract, valued at $3,855.49, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of September 29, 2023, and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...